Lv5
1440 积分 2022-03-29 加入
Malhotra J, Marchlewicz EH, Zhang Y, et al. Real-World Clinical and Economic Consequences of Next-Generation ALK+ TKIs in Patients with TKI-Naïve ALK+ Metastatic NSCLC in the United States
2小时前
待确认
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
10个月前
已完结
Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study
1年前
已关闭
皖公网安备34019202002308
